Recombinant full length protein corresponding to Human VIPR1 aa 1-457.Sequence: MRPPSPLPARWLCVLAGALAWALGPAGGQAARLQEECDYVQMIEVQHKQC LEEAQLENETIGCSKMWDNLTCWPATPRGQVVVLACPLIFKLFSSIQGRN VSRSCTDEGWTHLEPGPYPIACGLDDKAASLDEQQTMFYGSVKTGYTIGY GLSLATLLVATAILSLFRKLHC
Conjugate
Unconjugated
Applications
Application Notes
WB: 1 μg/ml.
Target
Alternative Names
VIPR1; vasoactive intestinal peptide receptor 1; vasoactive intestinal polypeptide receptor 1; HVR1; RDC1; VIP and PACAP receptor 1; VPAC1; VPAC1R; VIP receptor, type I; PACAP type II receptor; pituitary adenylate cyclase activating polypeptide receptor,
VIPR1 (vasoactive intestinal peptide receptor 1) is a protein-coding gene. Diseases associated with VIPR1 include scimitar syndrome, and idiopathic achalasia, and among its related super-pathways are Signaling by GPCR and Class A/1 (Rhodopsin-like receptors). GO annotations related to this gene include vasoactive intestinal polypeptide receptor activity. An important paralog of this gene is GLP1R.
Pathway
Class B/2 (Secretin family receptors); G alpha (s) signalling events; GPCR downstream signaling; GPCR ligand binding; GPCRs, Class B Secretin-like; Glucagon-type ligand receptors; Glucocorticoid receptor regulatory network
Citations
Publication ()
Have you cited DPABH-09690 in a publication? Let us know and earn a reward for your research.
My Review for Anti-VIPR1 (full length) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.